Register for our free email digests:
Transcept Pharmaceuticals Inc.
Division of Paratek Pharmaceuticals Inc.
www.transcept.com
Latest From Transcept Pharmaceuticals Inc.
ICAAC 2015: Scrip Connects With Cidara, MerLion And Paratek
Scrip caught up with several biopharma executives on Sept. 18 during the Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and International Congress of Chemotherapy and Infection (ICC) in San Diego to discuss the status of their anti-infective drug development programs.
US Capitol Capsule: NIH collaboration sheds light on sleep deprivation's toll
Research has shown that going without 7-8 hours of sleep each night takes a great toll on the human body, resulting in an increased risk for obesity, diabetes, cardiovascular disease, mental illness, cancer growth, Alzheimer's disease and other health problems, according to the National Institutes of Health (NIH).
Deals Shaping The Medical Industry, September 2014
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced June-August 2014.
Reinvigorated Antibiotics Pipeline Could Produce Four NMEs In 2014
With two novel antibiotics approved and two more under review, 2014 is seeing the end of a long lean period for antibacterial R&D, helped by incentives like Qualified Infectious Disease Product designation. But only one candidate, Cubist’s ceftozolane/tazobactam, addresses the urgent need to target resistant Gram-negative bacteria.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Drug Delivery
- Therapeutic Areas
- Neurology, Nervous System
- Alias(es)
- TransOral Pharmaceuticals Inc.
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Paratek Pharmaceuticals Inc.
- Senior Management
-
Glenn A Oclassen, Pres. & CEO
Nikhilesh Singh, PhD, SVP, CSO
John A Kollins, SVP, CBO - Contact Info
-
Transcept Pharmaceuticals Inc.
Phone: (510) 215-3500
1003 W. Cutting Blvd.
Ste. 110
Pt. Richmond, CA 94804
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice